3-(5-chlorofuran-2-yl)-5-methyl-4-phenylisoxazole and mofezolac

3-(5-chlorofuran-2-yl)-5-methyl-4-phenylisoxazole has been researched along with mofezolac* in 1 studies

Other Studies

1 other study(ies) available for 3-(5-chlorofuran-2-yl)-5-methyl-4-phenylisoxazole and mofezolac

ArticleYear
Structural basis for selective inhibition of Cyclooxygenase-1 (COX-1) by diarylisoxazoles mofezolac and 3-(5-chlorofuran-2-yl)-5-methyl-4-phenylisoxazole (P6).
    European journal of medicinal chemistry, 2017, Sep-29, Volume: 138

    The diarylisoxazole molecular scaffold is found in several NSAIDs, especially those with high selectivity for COX-1. Here, we have determined the structural basis for COX-1 binding to two diarylisoxazoles: mofezolac, which is polar and ionizable, and 3-(5-chlorofuran-2-yl)-5-methyl-4-phenylisoxazole (P6) that has very low polarity. X-ray analysis of the crystal structures of COX-1 bound to mofezolac and 3-(5-chlorofuran-2-yl)-5-methyl-4-phenylisoxazole allowed the identification of specific binding determinants within the enzyme active site, relevant to generate structure/activity relationships for diarylisoxazole NSAIDs.

    Topics: Cyclooxygenase 1; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Humans; Isoxazoles; Molecular Structure; Structure-Activity Relationship

2017